This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Alhaddad, I. A. Articles by Brown, E. J. Search for Related Content PubMed PubMed Citation Articles by Alhaddad, I. A. Articles by Brown, E. J., Jr

(Circulation. 1995;91:2819-2823.)
© 1995 American Heart Association, Inc.

Articles

Aspirin Enhances the Benefits of Late Reperfusion on Infarct Shape

A Possible Mechanism of the Beneficial Effects of Aspirin on Survival After Acute Myocardial Infarction

Imad A. Alhaddad, MD; Lidia Tkaczevski, MD; Faizi Siddiqui, BA; Rabia Mir, MD; Edward J. Brown, Jr, MD

From the Division of Cardiology, Departments of Medicine and Pathology (L.T., R.M.), State University of New York at Stony Brook, Nassau County Medical Center, East Meadow.

Background The time window of the benefits of late reperfusion on infarct shape is limited. In rats, these benefits diminish in a wave front over time, with minimal benefits when reperfusion follows 16 hours of coronary occlusion. The mechanism of the benefits of aspirin on survival after acute myocardial infarction is unknown. The purpose of this study was to test the ability of aspirin to enhance the benefits of late coronary artery reperfusion on infarct shape and to examine the mechanism of the benefits of aspirin on infarct shape.

Methods and Results Rats were entered into two different protocols, the morphometric and the histological protocols. In the morphometric protocol, rats were randomized into two groups: the aspirin group, in which rats underwent left coronary artery occlusion followed by treatment with aspirin (12 mg/kg IV), and the control group, in which rats underwent left coronary artery occlusion followed by treatment with placebo. Rats in both groups were reperfused 8 hours after coronary occlusion. Rats in the aspirin group received aspirin in the drinking water (12±2 mg/kg daily). Morphometric analysis was performed 2 weeks after acute myocardial infarction. In the histological protocol, rats underwent the same randomization, coronary occlusion, and reperfusion protocols. Hearts were removed 24 hours after coronary occlusion, and microvessels were assessed for patency. Infarct size expressed as a percent of circumference was similar in the aspirin and placebo treatment groups (28±2% versus 33±3%, P=NS). Septal thickness was also similar in both groups (1.8±0.1 versus 2.1±0.1 mm, P=NS for aspirin versus placebo). The aspirin-treated group had thicker infarcts compared with the placebo-treated group (0.8±0.1 versus 0.5±0.1 mm, P<.05) and less expanded infarcts (expansion index, 1.2±0.1 versus 2.0±0.2, P<.05). Aspirin was associated with increased patency of the microvessels in the infarcted area compared with the placebo group (96% versus 64% of microvessels patent, P<.001).

Conclusions Aspirin enhances the benefit of late coronary artery reperfusion on infarct shape after 8 hours of coronary occlusion. The benefits of aspirin on infarct shape after late reperfusion are related to increased patency of the microvessels in the infarcted area.

Key Words: aspirin • reperfusion • infarction

This article has been cited by other articles:

				T. Kohno, T. Anzai, K. Naito, T. Miyasho, M. Okamoto, H. Yokota, S. Yamada, Y. Maekawa, T. Takahashi, T. Yoshikawa, et al. Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling Cardiovasc Res, February 15, 2009; 81(3): 565 - 573. [Abstract] [Full Text] [PDF]

				Y. Sugano, T. Anzai, T. Yoshikawa, Y. Maekawa, T. Kohno, K. Mahara, K. Naito, and S. Ogawa Granulocyte colony-stimulating factor attenuates early ventricular expansion after experimental myocardial infarction Cardiovasc Res, February 1, 2005; 65(2): 446 - 456. [Abstract] [Full Text] [PDF]

				B.-q. Zhu, R. E Sievers, A. E. Browne, R. J Lee, K. Chatterjee, W. Grossman, J. S Karliner, and W. W Parmley Comparative effects of aspirin with ACE inhibitor or angiotensin receptor blocker on myocardial infarction and vascular function Journal of Renin-Angiotensin-Aldosterone System, March 1, 2003; 4(1): 31 - 37. [Abstract] [PDF]

				D. Fraccarollo, P. Galuppo, J. Bauersachs, and G. Ertl Collagen accumulation after myocardial infarction: effects of ETA receptor blockade and implications for early remodeling: Presented in part at the 72nd Scientific Session of the American Heart Association, Atlanta, GA, USA, November 7-10, 1999, and published in abstract form (Circulation 1999;100(Suppl. 1):562) Cardiovasc Res, June 1, 2002; 54(3): 559 - 567. [Abstract] [Full Text] [PDF]

				M. E. Khalil, E. N. Heller, F. Boctor, E. J. Brown Jr, and I. A. Alhaddad Ventricular Free Wall Rupture in Acute Myocardial Infarction Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2001; 6(3): 231 - 236. [Abstract] [PDF]

				J. Leor, H. Reicher-Reiss, U. Goldbourt, V. Boyko, S. Gottlieb, A. Battler, and S. Behar Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors: A cohort study of 11,575 patients with coronary artery disease J. Am. Coll. Cardiol., June 1, 1999; 33(7): 1920 - 1925. [Abstract] [Full Text] [PDF]